New York Rep. Chris Collins, who faces insider trading charges stemming from his investment in an Australian biotech company, will get his day in court on Feb. 3, 2020.
Assistant U.S. Attorney Scott Hartman repeatedly asked to move up the trial date, stating there is a “strong public interest in seeing this case resolved in 2019,” CNN reported.
Subscribe
‘Enforcement 40’ for 2020
Our Sponsors
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn